| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Generate Biomedicines, Inc.'s insiders have reduced their positions by a net 1,000 shares worth roughly $16K.
GENB sits in the Biotechnology industry within the Healthcare sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 13.70M | - | - | |
| Dir | 724.2K | - | - | |
| CEO | 572.7K | $6.87M | - | |
| Other | 295.6K | - | - | |
| Dir | 231.5K | $3.70M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Arnold Frances | Director | Sell | 1,000 | $16.00 | $16,002.00 | -0.4% | |
| Mar 4, 2026 | Nally Michael | Chief Executive Officer | Buy | 20,000 | $12.00 | $240,000.00 | +3.6% | |
| Mar 2, 2026 | Grous Beth | Chief People Officer | Buy | 300 | $16.00 | $4,800.00 | New | |
| Mar 2, 2026 | Mendillo Jane L | Director | Buy | 1,500 | $16.00 | $24,000.00 | New | |
| Mar 2, 2026 | Silvers Jason | President &CFO | Buy | 2,000 | $16.00 | $32,000.00 | -400.0% | |
| Mar 2, 2026 | Afeyan Noubar74 | Director, 10% Owner | Buy | 4,687,500 | $16.00 | $75,000,000.00 | +28.4% | |
| Mar 2, 2026 | Afeyan Noubar74 | Director, 10% Owner | Buy | 4,687,500 | $16.00 | $75,000,000.00 | +28.4% |